Results 221 to 230 of about 1,103,970 (339)

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Beyond the Heart: The Neuroprotective Potential of Nebivolol in Acute Myocardial Infarction. [PDF]

Life (Basel)
Mercanoglu G, Bamac OE, Sennazlı G, Kalaycı R, Mercanoglu F.   +4 more
europepmc   +1 more source

HIV infection and the risk of acute myocardial infarction.

JAMA Internal Medicine, 2013
M. Freiberg, C. Chang, L. Kuller, M. Skanderson, Elliott Lowy, K. Kraemer, A. Butt, M. Bidwell Goetz, D. Leaf, K. Oursler, D. Rimland, M. R. Rodriguez Barradas, Sheldon T. Brown, C. Gibert, K. McGinnis, K. Crothers, Jason J. Sico, H. Crane, A. Warner, S. Gottlieb, J. Gottdiener, R. Tracy, M. Budoff, C. Watson, K. Armah, D. Doebler, K. Bryant, A. Justice   +27 more
semanticscholar   +1 more source

Mitochondria in acute myocardial infarction and cardioprotection

EBioMedicine, 2020
C. Ramachandra, S. Hernandez-Resendiz, G. Crespo-Avilan, Ying-Hsi Lin, D. Hausenloy   +4 more
semanticscholar   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Prediction of Cardiogenic Shock in Acute Myocardial Infarction Patients Using a Nomogram. [PDF]

J Clin Med
Wang J, Zhao C, Yang C, Dong Y, Yang X, Sun C.   +5 more
europepmc   +1 more source

Complications of Endovascular Aneurysm Repair: Mortality, Myocardial Infarction and Acute Kidney Injury

, 2018
Pedro Reis, M Morgado, Inês Valdoleiros, Marina Dias‐Neto, Joana Mourão   +4 more
openalex   +2 more sources

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Macrophage polarization in acute myocardial infarction: multidimensional regulation and emerging therapeutic opportunities. [PDF]

Front Immunol
Ye Z, Wang B, Wan Z, Guo J.
europepmc   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source